Accelerating India's Journey to Eliminate Viral Hepatitis before 2030
17 - 18 January 2025
ITC Grand Chola
Indian Hepatitis
Summit 2025
Indian Hepatitis Summit 2025 will convene leading experts, global organisations, and key stakeholders for developing innovative strategies to eradicate viral Hepatitis by 2030.
Organised by the Chennai Liver Foundation in collaboration with the World Hepatitis Alliance, this event will advance India’s commitment to eliminating the spread of viral hepatitis.
Organizing Committee
Committed to advancing hepatitis care, we bring together a dedicated committee of experts worldwide. Organisations joining hands towards a hepatitis-free nation
According to the latest WHO report, India ranks second globally, following China, in terms of viral hepatitis burden, with 29.8 million cases of hepatitis B and 5.5 million hepatitis C infections recorded in 2022.
Indian Hepatitis Summit 2025 aims to address the critical gaps in awareness, access to care, and healthcare infrastructure contributing to these alarming statistics. With one unified vision on “Accelerating India’s commitment to Eliminate Viral Hepatitis Before 2030” the summit will focus on driving awareness and implementing innovative strategies to combat the growing incidence of viral hepatitis in India.
Register Now
Join us as we engage in impactful discussions, share best practices, and forge collaborations that will shape the future of hepatitis care in our nation.
Speakers
Committed to advancing hepatitis care, we bring together a dedicated committee of experts worldwide. Organisations joining hands towards a hepatitis-free nation
Dr. Ajeet Singh Bhadoria
Associate Professor, AIIMS
Mr. Arun Jain
Founder and CMD of Intellect Design Arena Ltd, Founder of Mission Samriddhi
Dr. Amit Goel
Professor & Head, SGPGI
Mr. Anil Parmar
Vice President, United Way Mumbai
Dr. Arindam Ray
Country Lead, New Vaccines and Immunization Systems, Bill & Melinda Gates Foundation
Dr. Asha Hegde
Director, South Asia, HIV – Hepatitis PATH
Mr. G N Balakrishnan
Director, Sales & BD, Commercial Operations,Zoho Corporation
Mr. Cary James
Chief Executive, The World Hepatitis Alliance
Dr. Gagandeep Singh Grover
Assistant Director, Department of Health and Family Welfare, Punjab
Prof. Gaurav Raina
Professor, Electrical Engineering, IIT Madras
Dr. Ganeshkumar Parasuraman
Scientist E, ICMR – NIE
Mr. Giten Khwairakpam
Program Manager, Community and Policy, TREAT Asia/amFAR
Ms. Jessica Hicks
Director, The World Hepatitis Alliance
Dr. John W. Ward
Director, Coalition for Global Hepatitis Elimination
Dr. Jyotsna Sistla
Manager of HIV & Hepatitis , WJCF
Dr. Harikumar
State Nodal Officer, NVHCP, Kerala
Dr. Kavita S. Lole
Scientist ‘G’ ICMR-National Institute of Virology
Dr. Kimberly Green
Global Director, Primary Health Care, PATH
Ms. Kousalya Periasamy
Founder, Positive Women Network
Dr. N. Kumarasamy
Director, VHS Infectious Diseases Medical Centre
Dr. Manoj Murhekar
Director, Indian Council of Medical Research – NIE
Dr. Murugan
Hepatologist, Apollo Hospitals
Ms. Mila Maistat
Senior Manager, Medicines Patent Pool
Dr. Oriel Fernandes
Director, Clinton Health Access Initiative (CHAI)
Mr. Patrick Nado
Regional Director, Central Asia, CDC
Dr. VK Paul
Member-Healthcare, NITI Aayog
Dr. Po-Lin Chan
Regional Advisor for Hepatitis, HIV, and STIs , WHO
Dr. Priya Abraham
Director, National Institute of Virology and Professor of Clinical Virology, CMC
Dr. Prakash Fernandes
Cipla Foundation
Dr. Rakesh Aggarwal
Director, JIPMER
Mr. Rajkumar Nalinikanta
President, Community Network for Empowerment (CoNE)
Ms. Rachel Halford P
President, World Hepatitis Alliance (WHA)
Dr. B. B. Rewari
Visiting Professor (Epi) & Public Health Specialist, ILBS
Dr. Reshu Agarwal
Technical Lead, HIV & Hepatitis , WHO India
Dr. Saravanamurthy
P. Sakthivel
Lead – Viral Hepatitis, PATH
Dr. Santhosh Jacob
Director, Orthopedics and sports injury management, Be Well Hospitals
Dr. R.P. Shanmugam
Founder, Chennai Liver Foundation
Dr. Shiv Kumar Sarin
Director, Institute Of Liver And Biliary Sciences
Ms. Sharin D'souza
Assistant Research Coordinator, iHEAR, Sangath
Dr. K.S.Somasekhar Rao
Gastroenterologist and Hepatologist, Yashoda hospital
Dr. Soumya Swaminathan
Former chief scientist, WHO
Dr. R. Thara
Vice Chairman, SCARF
Dr. Vinay kumar
Deputy Director, Health and Family Welfare Department, Government of Tamil Nadu
Dr. Viswajeet Kumar
Founder, Community Empowerment Lab
Dr. Vivekanandan Shanmugam
Managing Trustee, Chennai Liver Foundation
Taking place at the hub of medical excellence, Chennai
Recognised for its advanced medical facilities and expertise, Chennai serves as an ideal setting for this pivotal event. The summit aims to facilitate meaningful dialogue and foster collaboration to develop actionable strategies for combating hepatitis nationwide. As a city renowned for its leadership in healthcare innovation, Chennai is uniquely positioned to host this critical discussion that will shape the future of hepatitis elimination in India by 2030, marking a significant milestone in its continued legacy of medical excellence.
